Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

The New York Times - 4 Feb 2015 03:41
Global sales of the drug, in its first year on the market, fell short of those of AbbVie's Humira, but Sovaldi outsold Humira in the United States.
Full Article at The New York Times

More Business News
6
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard